Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Lisa Ann Maier

TitleProfessor
InstitutionUniversity of Colorado Denver - Anschutz Medical Campus
DepartmentSOM-MED
Address2SOM
School of Medicine
13001 East 17th Place
Aurora CO 80045
Phone303/315-7767

 Bibliographic 
 selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Judson MA, Costabel U, Drent M, Wells A, Maier L, Koth L, Shigemitsu H, Culver DA, Gelfand J, Valeyre D, Sweiss N, Crouser E, Morgenthau AS, Lower EE, Azuma A, Ishihara M, Morimoto S, Tetsuo Yamaguchi T, Shijubo N, Grutters JC, Rosenbach M, Li HP, Rottoli P, Inoue Y, Prasse A, Baughman RP, Organ Assessment Instrument Investigators TW. The WASOG Sarcoidosis Organ Assessment Instrument: An update of a previous clinical tool. Sarcoidosis Vasc Diffuse Lung Dis. 2014; 31(1):19-27.
    View in: PubMed
  2. Bowerman NA, Falta MT, Mack DG, Wehrmann F, Crawford F, Mroz MM, Maier LA, Kappler JW, Fontenot AP. Identification of Multiple Public TCR Repertoires in Chronic Beryllium Disease. J Immunol. 2014 May 15; 192(10):4571-80.
    View in: PubMed
  3. Stark M, Lerman Y, Kapel A, Pardo A, Schwarz Y, Newman L, Maier L, Fireman E. Biological exposure metrics of beryllium-exposed dental technicians. Arch Environ Occup Health. 2014; 69(2):89-99.
    View in: PubMed
  4. Chain JL, Martin AK, Mack DG, Maier LA, Palmer BE, Fontenot AP. Impaired function of CTLA-4 in the lungs of patients with chronic beryllium disease contributes to persistent inflammation. J Immunol. 2013 Aug 15; 191(4):1648-56.
    View in: PubMed
  5. Falta MT, Pinilla C, Mack DG, Tinega AN, Crawford F, Giulianotti M, Santos R, Clayton GM, Wang Y, Zhang X, Maier LA, Marrack P, Kappler JW, Fontenot AP. Identification of beryllium-dependent peptides recognized by CD4+ T cells in chronic beryllium disease. J Exp Med. 2013 Jul 1; 210(7):1403-18.
    View in: PubMed
  6. Mayer AS, Brazile WJ, Erb SA, Barker EA, Miller CM, Mroz MM, Maier LA, Van Dyke MV. Developing effective health and safety training materials for workers in beryllium-using industries. J Occup Environ Med. 2013 Jul; 55(7):746-51.
    View in: PubMed
  7. Pacheco K, Barker L, Maier L, Erb S, Sills M, Knight V. Development of a validated blood test for nickel sensitization. J Allergy Clin Immunol. 2013 Sep; 132(3):767-9.
    View in: PubMed
  8. Freeman AM, Curran-Everett D, Weinberger HD, Fenster BE, Buckner JK, Gottschall EB, Sauer WH, Maier LA, Hamzeh NY. Predictors of cardiac sarcoidosis using commonly available cardiac studies. Am J Cardiol. 2013 Jul 15; 112(2):280-5.
    View in: PubMed
  9. Fireman E, Shai AB, Lerman Y, Topilsky M, Blanc PD, Maier L, Li L, Chandra S, Abraham JM, Fomin I, Aviram G, Abraham JL. Chest wall shrapnel-induced beryllium-sensitization and associated pulmonary disease. Sarcoidosis Vasc Diffuse Lung Dis. 2012 Oct; 29(2):147-50.
    View in: PubMed
  10. Silveira LJ, McCanlies EC, Fingerlin TE, Van Dyke MV, Mroz MM, Strand M, Fontenot AP, Bowerman N, Dabelea DM, Schuler CR, Weston A, Maier LA. Chronic beryllium disease, HLA-DPB1, and the DP peptide binding groove. J Immunol. 2012 Oct 15; 189(8):4014-23.
    View in: PubMed
  11. Maier LA, Barkes BQ, Mroz M, Rossman MD, Barnard J, Gillespie M, Martin A, Mack DG, Silveira L, Sawyer RT, Newman LS, Fontenot AP. Infliximab therapy modulates an antigen-specific immune response in chronic beryllium disease. Respir Med. 2012 Dec; 106(12):1810-3.
    View in: PubMed
  12. Hines SE, Pacheco K, Maier LA. The role of lymphocyte proliferation tests in assessing occupational sensitization and disease. Curr Opin Allergy Clin Immunol. 2012 Apr; 12(2):102-10.
    View in: PubMed
  13. Martin AK, Mack DG, Falta MT, Mroz MM, Newman LS, Maier LA, Fontenot AP. Beryllium-specific CD4+ T cells in blood as a biomarker of disease progression. J Allergy Clin Immunol. 2011 Nov; 128(5):1100-6.e1-5.
    View in: PubMed
  14. Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Cragle DL, Tankersley WG, Wells SM, Newman LS, Maier LA. Exposure and genetics increase risk of beryllium sensitisation and chronic beryllium disease in the nuclear weapons industry. Occup Environ Med. 2011 Nov; 68(11):842-8.
    View in: PubMed
  15. Ribeiro M, Fritscher LG, Al-Musaed AM, Balter MS, Hoffstein V, Mazer BD, Maier LA, Liss GM, Tarlo SM. Search for chronic beryllium disease among sarcoidosis patients in Ontario, Canada. Lung. 2011 Jun; 189(3):233-41.
    View in: PubMed
  16. Van Dyke MV, Martyny JW, Mroz MM, Silveira LJ, Strand M, Fingerlin TE, Sato H, Newman LS, Maier LA. Risk of chronic beryllium disease by HLA-DPB1 E69 genotype and beryllium exposure in nuclear workers. Am J Respir Crit Care Med. 2011 Jun 15; 183(12):1680-8.
    View in: PubMed
  17. Tooker BC, Bowler RP, Orcutt JM, Maier LA, Christensen HM, Newman LS. SELDI-TOF derived serum biomarkers failed to differentiate between patients with beryllium sensitisation and patients with chronic beryllium disease. Occup Environ Med. 2011 Oct; 68(10):759-64.
    View in: PubMed
  18. Sawyer RT, Maier LA. Chronic beryllium disease: an updated model interaction between innate and acquired immunity. Biometals. 2011 Feb; 24(1):1-17.
    View in: PubMed
  19. Middleton DC, Mayer AS, Lewin MD, Mroz MM, Maier LA. Interpreting borderline BeLPT results. Am J Ind Med. 2011 Mar; 54(3):205-9.
    View in: PubMed
  20. Sato H, Woodhead FA, Ahmad T, Grutters JC, Spagnolo P, van den Bosch JM, Maier LA, Newman LS, Nagai S, Izumi T, Wells AU, du Bois RM, Welsh KI. Sarcoidosis HLA class II genotyping distinguishes differences of clinical phenotype across ethnic groups. Hum Mol Genet. 2010 Oct 15; 19(20):4100-11.
    View in: PubMed
  21. Pacheco KA, Rose CS, Silveira LJ, Van Dyke MV, Goelz K, MacPhail K, Maier LA. Gene-environment interactions influence airways function in laboratory animal workers. J Allergy Clin Immunol. 2010 Aug; 126(2):232-40.
    View in: PubMed
  22. Mack DG, Lanham AM, Falta MT, Palmer BE, Maier LA, Fontenot AP. Deficient and dysfunctional regulatory T cells in the lungs of chronic beryllium disease subjects. Am J Respir Crit Care Med. 2010 Jun 1; 181(11):1241-9.
    View in: PubMed
  23. Sato H, Silveira L, Spagnolo P, Gillespie M, Gottschall EB, Welsh KI, du Bois RM, Newman LS, Maier LA. CC chemokine receptor 5 gene polymorphisms in beryllium disease. Eur Respir J. 2010 Aug; 36(2):331-8.
    View in: PubMed
  24. Dobis DR, Sawyer RT, Gillespie MM, Newman LS, Maier LA, Day BJ. Sulfasalazine and mesalamine modulate beryllium-specific lymphocyte proliferation and inflammatory cytokine production. Am J Respir Cell Mol Biol. 2010 Oct; 43(4):458-64.
    View in: PubMed
  25. Mroz MM, Maier LA, Strand M, Silviera L, Newman LS. Beryllium lymphocyte proliferation test surveillance identifies clinically significant beryllium disease. Am J Ind Med. 2009 Oct; 52(10):762-73.
    View in: PubMed
  26. Mack DG, Lanham AM, Palmer BE, Maier LA, Fontenot AP. CD27 expression on CD4+ T cells differentiates effector from regulatory T cell subsets in the lung. J Immunol. 2009 Jun 1; 182(11):7317-24.
    View in: PubMed
  27. Maier LA, Brown KK. Exposure-related diffuse lung diseases. Semin Respir Crit Care Med. 2008 Dec; 29(6):589-90.
    View in: PubMed
  28. Pacheco K, Maier L, Silveira L, Goelz K, Noteware K, Luna B, du Bois R, Murphy J, Rose C. Association of Toll-like receptor 4 alleles with symptoms and sensitization to laboratory animals. J Allergy Clin Immunol. 2008 Nov; 122(5):896-902.e4.
    View in: PubMed
  29. Mack DG, Lanham AK, Palmer BE, Maier LA, Watts TH, Fontenot AP. 4-1BB enhances proliferation of beryllium-specific T cells in the lung of subjects with chronic beryllium disease. J Immunol. 2008 Sep 15; 181(6):4381-8.
    View in: PubMed
  30. Wasfi YS, Silveira LJ, Jonth A, Hokanson JE, Fingerlin T, Sato H, Parsons CE, Lympany P, Welsh K, du Bois RM, Newman LS, Maier LA. Fas promoter polymorphisms: genetic predisposition to sarcoidosis in African-Americans. Tissue Antigens. 2008 Jul; 72(1):39-48.
    View in: PubMed
  31. Samuel G, Maier LA. Immunology of chronic beryllium disease. Curr Opin Allergy Clin Immunol. 2008 Apr; 8(2):126-34.
    View in: PubMed
  32. Palmer BE, Mack DG, Martin AK, Gillespie M, Mroz MM, Maier LA, Fontenot AP. Up-regulation of programmed death-1 expression on beryllium-specific CD4+ T cells in chronic beryllium disease. J Immunol. 2008 Feb 15; 180(4):2704-12.
    View in: PubMed
  33. Gingo MR, Silveira LJ, Miller YE, Friedlander AL, Cosgrove GP, Chan ED, Maier LA, Bowler RP. Tumour necrosis factor gene polymorphisms are associated with COPD. Eur Respir J. 2008 May; 31(5):1005-12.
    View in: PubMed
  34. Maier LA, Martyny JW, Liang J, Rossman MD. Recent chronic beryllium disease in residents surrounding a beryllium facility. Am J Respir Crit Care Med. 2008 May 1; 177(9):1012-7.
    View in: PubMed
  35. Dobis DR, Sawyer RT, Gillespie MM, Huang J, Newman LS, Maier LA, Day BJ. Modulation of lymphocyte proliferation by antioxidants in chronic beryllium disease. Am J Respir Crit Care Med. 2008 May 1; 177(9):1002-11.
    View in: PubMed
  36. Sato H, Spagnolo P, Silveira L, Welsh KI, du Bois RM, Newman LS, Maier LA. BTNL2 allele associations with chronic beryllium disease in HLA-DPB1*Glu69-negative individuals. Tissue Antigens. 2007 Dec; 70(6):480-6.
    View in: PubMed
  37. Jonth AC, Silveira L, Fingerlin TE, Sato H, Luby JC, Welsh KI, Rose CS, Newman LS, du Bois RM, Maier LA. TGF-beta 1 variants in chronic beryllium disease and sarcoidosis. J Immunol. 2007 Sep 15; 179(6):4255-62.
    View in: PubMed
  38. Palmer BE, Mack DG, Martin AK, Maier LA, Fontenot AP. CD57 expression correlates with alveolitis severity in subjects with beryllium-induced disease. J Allergy Clin Immunol. 2007 Jul; 120(1):184-91.
    View in: PubMed
  39. Sato H, Silveira L, Fingerlin T, Dockstader K, Gillespie M, Lagan AL, Lympany P, Sawyer RT, du Bois RM, Welsh KI, Maier LA. TNF polymorphism and bronchoalveolar lavage cell TNF-alpha levels in chronic beryllium disease and beryllium sensitization. J Allergy Clin Immunol. 2007 Mar; 119(3):687-96.
    View in: PubMed
  40. Sawyer RT, Fontenot AP, Barnes TA, Parsons CE, Tooker BC, Maier LA, Gillespie MM, Gottschall EB, Silveira L, Hagman J, Newman LS. Beryllium-induced TNF-alpha production is transcription-dependent in chronic beryllium disease. Am J Respir Cell Mol Biol. 2007 Feb; 36(2):191-200.
    View in: PubMed
  41. Bekris LM, Viernes HM, Farin FM, Maier LA, Kavanagh TJ, Takaro TK. Chronic beryllium disease and glutathione biosynthesis genes. J Occup Environ Med. 2006 Jun; 48(6):599-606.
    View in: PubMed
  42. Wasfi YS, Rose CS, Murphy JR, Silveira LJ, Grutters JC, Inoue Y, Judson MA, Maier LA. A new tool to assess sarcoidosis severity. Chest. 2006 May; 129(5):1234-45.
    View in: PubMed
  43. Bill JR, Mack DG, Falta MT, Maier LA, Sullivan AK, Joslin FG, Martin AK, Freed BM, Kotzin BL, Fontenot AP. Beryllium presentation to CD4+ T cells is dependent on a single amino acid residue of the MHC class II beta-chain. J Immunol. 2005 Nov 15; 175(10):7029-37.
    View in: PubMed
  44. Fontenot AP, Maier LA. Genetic susceptibility and immune-mediated destruction in beryllium-induced disease. Trends Immunol. 2005 Oct; 26(10):543-9.
    View in: PubMed
  45. Fontenot AP, Palmer BE, Sullivan AK, Joslin FG, Wilson CC, Maier LA, Newman LS, Kotzin BL. Frequency of beryllium-specific, central memory CD4+ T cells in blood determines proliferative response. J Clin Invest. 2005 Oct; 115(10):2886-93.
    View in: PubMed
  46. Newman LS, Maier LA, Martyny JW, Mroz MM, VanDyke M, Sackett HM. Beryllium workers' health risks. J Occup Environ Hyg. 2005 Jun; 2(6):D48-50.
    View in: PubMed
  47. Pott GB, Palmer BE, Sullivan AK, Silviera L, Maier LA, Newman LS, Kotzin BL, Fontenot AP. Frequency of beryllium-specific, TH1-type cytokine-expressing CD4+ T cells in patients with beryllium-induced disease. J Allergy Clin Immunol. 2005 May; 115(5):1036-42.
    View in: PubMed
  48. Sawyer RT, Dobis DR, Goldstein M, Velsor L, Maier LA, Fontenot AP, Silveira L, Newman LS, Day BJ. Beryllium-stimulated reactive oxygen species and macrophage apoptosis. Free Radic Biol Med. 2005 Apr 1; 38(7):928-37.
    View in: PubMed
  49. Newman LS, Mroz MM, Balkissoon R, Maier LA. Beryllium sensitization progresses to chronic beryllium disease: a longitudinal study of disease risk. Am J Respir Crit Care Med. 2005 Jan 1; 171(1):54-60.
    View in: PubMed
  50. Sackett HM, Maier LA, Silveira LJ, Mroz MM, Ogden LG, Murphy JR, Newman LS. Beryllium medical surveillance at a former nuclear weapons facility during cleanup operations. J Occup Environ Med. 2004 Sep; 46(9):953-61.
    View in: PubMed
  51. Sawyer RT, Day BJ, Fadok VA, Chiarappa-Zucca M, Maier LA, Fontenot AP, Silveira L, Newman LS. Beryllium-ferritin: lymphocyte proliferation and macrophage apoptosis in chronic beryllium disease. Am J Respir Cell Mol Biol. 2004 Oct; 31(4):470-7.
    View in: PubMed
  52. Maier LA. Is smoking beneficial for granulomatous lung diseases? Am J Respir Crit Care Med. 2004 Apr 15; 169(8):893-5.
    View in: PubMed
  53. Sawyer RT, Parsons CE, Fontenot AP, Maier LA, Gillespie MM, Gottschall EB, Silveira L, Newman LS. Beryllium-induced tumor necrosis factor-alpha production by CD4+ T cells is mediated by HLA-DP. Am J Respir Cell Mol Biol. 2004 Jul; 31(1):122-30.
    View in: PubMed
  54. Maier LA, McGrath DS, Sato H, Lympany P, Welsh K, Du Bois R, Silveira L, Fontenot AP, Sawyer RT, Wilcox E, Newman LS. Influence of MHC class II in susceptibility to beryllium sensitization and chronic beryllium disease. J Immunol. 2003 Dec 15; 171(12):6910-8.
    View in: PubMed
  55. Maier LA, Kittle LA, Mroz MM, Newman LS. Beryllium-stimulated neopterin as a diagnostic adjunct in chronic beryllium disease. Am J Ind Med. 2003 Jun; 43(6):592-601.
    View in: PubMed
  56. Maier LA. Genetic and exposure risks for chronic beryllium disease. Clin Chest Med. 2002 Dec; 23(4):827-39.
    View in: PubMed
  57. Maier LA. Clinical approach to chronic beryllium disease and other nonpneumoconiotic interstitial lung diseases. J Thorac Imaging. 2002 Oct; 17(4):273-84.
    View in: PubMed
  58. Kittle LA, Sawyer RT, Fadok VA, Maier LA, Newman LS. Beryllium induces apoptosis in human lung macrophages. Sarcoidosis Vasc Diffuse Lung Dis. 2002 Jun; 19(2):101-13.
    View in: PubMed
  59. Fontenot AP, Maier LA, Canavera SJ, Hendry-Hofer TB, Boguniewicz M, Barker EA, Newman LS, Kotzin BL. Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung. J Immunol. 2002 Apr 1; 168(7):3627-34.
    View in: PubMed
  60. Maier L, Martyny J, Mroz M, McGrath D, Lympany P, duBois R, Zhang L, Murphy J, Newman LS. Genetic and environmental risk factors in beryllium sensitization and chronic beryllium disease. Chest. 2002 Mar; 121(3 Suppl):81S.
    View in: PubMed
  61. Sawyer RT, Maier LA, Kittle LA, Newman LS. Chronic beryllium disease: a model interaction between innate and acquired immunity. Int Immunopharmacol. 2002 Feb; 2(2-3):249-61.
    View in: PubMed
  62. Lundgren RA, Maier LA, Rose CS, Balkissoon RC, Newman LS. Indirect and direct gas exchange at maximum exercise in beryllium sensitization and disease. Chest. 2001 Nov; 120(5):1702-8.
    View in: PubMed
  63. Maier LA, Sawyer RT, Bauer RA, Kittle LA, Lympany P, McGrath D, Dubois R, Daniloff E, Rose CS, Newman LS. High beryllium-stimulated TNF-alpha is associated with the -308 TNF-alpha promoter polymorphism and with clinical severity in chronic beryllium disease. Am J Respir Crit Care Med. 2001 Oct 1; 164(7):1192-9.
    View in: PubMed
  64. Wang Z, Farris GM, Newman LS, Shou Y, Maier LA, Smith HN, Marrone BL. Beryllium sensitivity is linked to HLA-DP genotype. Toxicology. 2001 Aug 13; 165(1):27-38.
    View in: PubMed
  65. Duong TX, Suruda AJ, Maier LA. Interstitial fibrosis following hydrogen sulfide exposure. Am J Ind Med. 2001 Aug; 40(2):221-4.
    View in: PubMed
  66. Deubner D, Kelsh M, Shum M, Maier L, Kent M, Lau E. Beryllium sensitization, chronic beryllium disease, and exposures at a beryllium mining and extraction facility. Appl Occup Environ Hyg. 2001 May; 16(5):579-92.
    View in: PubMed
  67. Maier LA. Beryllium health effects in the era of the beryllium lymphocyte proliferation test. Appl Occup Environ Hyg. 2001 May; 16(5):514-20.
    View in: PubMed
  68. Maier LA, Sawyer RT, Tinkle SS, Kittle LA, Barker EA, Balkissoon R, Rose C, Newman LS. IL-4 fails to regulate in vitro beryllium-induced cytokines in berylliosis. Eur Respir J. 2001 Mar; 17(3):403-15.
    View in: PubMed
  69. Kelleher PC, Martyny JW, Mroz MM, Maier LA, Ruttenber AJ, Young DA, Newman LS. Beryllium particulate exposure and disease relations in a beryllium machining plant. J Occup Environ Med. 2001 Mar; 43(3):238-49.
    View in: PubMed
  70. Newman LS, Mroz MM, Maier LA, Daniloff EM, Balkissoon R. Efficacy of serial medical surveillance for chronic beryllium disease in a beryllium machining plant. J Occup Environ Med. 2001 Mar; 43(3):231-7.
    View in: PubMed
  71. Sawyer RT, Fadok VA, Kittle LA, Maier LA, Newman LS. Beryllium-stimulated apoptosis in macrophage cell lines. Toxicology. 2000 Aug 21; 149(2-3):129-42.
    View in: PubMed
  72. Farris GM, Newman LS, Frome EL, Shou Y, Barker E, Habbersett RC, Maier L, Smith HN, Marrone BL. Detection of beryllium sensitivity using a flow cytometric lymphocyte proliferation test: the Immuno-Be-LPT. Toxicology. 2000 Feb 21; 143(2):125-40.
    View in: PubMed
  73. Martyny JW, Hoover MD, Mroz MM, Ellis K, Maier LA, Sheff KL, Newman LS. Aerosols generated during beryllium machining. J Occup Environ Med. 2000 Jan; 42(1):8-18.
    View in: PubMed
  74. Wang Z, White PS, Petrovic M, Tatum OL, Newman LS, Maier LA, Marrone BL. Differential susceptibilities to chronic beryllium disease contributed by different Glu69 HLA-DPB1 and -DPA1 alleles. J Immunol. 1999 Aug 1; 163(3):1647-53.
    View in: PubMed
  75. Maier LA, Raynolds MV, Young DA, Barker EA, Newman LS. Angiotensin-1 converting enzyme polymorphisms in chronic beryllium disease. Am J Respir Crit Care Med. 1999 Apr; 159(4 Pt 1):1342-50.
    View in: PubMed
  76. Newman LS, Rose CS, Maier LA. Sarcoidosis. N Engl J Med. 1997 Apr 24; 336(17):1224-34.
    View in: PubMed
  77. Maier LA, Xu FJ, Hester S, Boyer CM, McKenzie S, Bruskin AM, Argon Y, Bast RC. Requirements for the internalization of a murine monoclonal antibody directed against the HER-2/neu gene product c-erbB-2. Cancer Res. 1991 Oct 1; 51(19):5361-9.
    View in: PubMed
Maier's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts
_
Co-Authors
_
Similar People
_
Same Department
Physical Neighbors
_